Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 42, 4300-4303, October 1, 1982]
© 1982 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whitehurst, G. B.
Right arrow Articles by Boohaker, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whitehurst, G. B.
Right arrow Articles by Boohaker, E. A.

Prostatic Hexosaminidase Activity in Patients with Benign Prostatic Hyperplasia and Prostatic Carcinoma1

Garnett B. Whitehurst, Jay P. Mashburn, Thomas G. Pretlow, II2, Edwin L. Bradley, Jr. and Emily A. Boohaker

Departments of Pathology [G. B. W., J. P. M., T. G. P., E. A. B.], Biochemistry [G. B. W., T. G. P.], and biostatistics [E. L. B.], University of Alabama in Birmingham, Birmingham, Alabama 35294

Hexosaminidase activity in prostatic tissue has been compared in 15 patients with benign prostatic hyperplasia and 15 patients with prostatic carcinoma. The ratio of enzymatic activity for the two substrates tested (p-nitrophenyl-2-acetamido-2- deoxy-ß-D-glucopyranoside and p-nitrophenyl-2-acetamido-2- deoxy-ß-D-galactopyranoside) was not significantly different in the two groups of patients. The proportion of hexosaminidase represented by the B isozyme was not significantly different for the two groups of patients. Prostatic tissue hexosaminidase was greater (p = 0.0141) in carcinomatous prostates than in hyperplastic prostates.

1 Supported by Grants CA 13148 and CA 31140 from the National Cancer Institute and by Grants PDT-126A and CD-141 from the American Cancer Society.

2 To whom requests for reprints should be addressed.

Received 3/11/82. Accepted 6/24/82.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1982 by the American Association for Cancer Research.